Targeted Delivery of Chemotherapeutic Agents for Osteosarcoma Treatment

Since osteosarcoma (OS) is an aggressive bone cancer with unknown molecular pathways of etiology and pathophysiology, improving patient survival has long been a challenge. The conventional therapy is a complex multidisciplinary management that include radiotherapy, chemotherapy which followed by sur...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Duoli, Wang, Zhuqian, Li, Jie, Guo, De-an, Lu, Aiping, Liang, Chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931218/
https://www.ncbi.nlm.nih.gov/pubmed/35311145
http://dx.doi.org/10.3389/fonc.2022.843345

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931218/
https://www.ncbi.nlm.nih.gov/pubmed/35311145
http://dx.doi.org/10.3389/fonc.2022.843345

Ejemplares similares